TONELLA, LUCA
Dettaglio
TONELLA, LUCA
Pubblicazioni
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.0 secondi).
Titolo | Data di pubblicazione | Autore(i) | |
---|---|---|---|
1 | Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone |
2 | Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit | 2021 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T. |
3 | CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study | 2022 | Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A. |
4 | Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials | 2021 | Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P. |
5 | Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study | 2021 | Barreiro-Capurro A.; Andres-Lencina J.J.; Podlipnik S.; Carrera C.; Requena C.; Manrique-Silva E.; Quaglino P.; Tonella L.; Jaka A.; Richarz N.; Rodriguez-Peralto J.L.; Ortiz P.; Boada A.; Ribero S.; Nagore E.; Malvehy J.; Puig S. |
6 | Effectiveness and Safety of Dupilumab for the Treatment of Atopic Dermatitis in Adult Cohort: a Real-Life Italian Tertiary Centre Experience. | 2022 | Ribero S, Giura MT, Viola R, Ramondetta A, Siliquini N, Cardone P, Tonella L, Quaglino P, Dapavo P, Panzone M, Ortoncelli M, Fierro MT. |
7 | Evolution of different clinical patterns of cutaneous lesions in a suspected COVID-19 patient | 2020 | Quaglino P.; Fava P.; Cariti C.; Ortoncelli M.; Aimetti M.; Milan A.; Dapavo P.; Tonella L.; Ribero S.; Fierro M.T. |
8 | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives | 2021 | Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P. |
9 | Infections in Sézary syndrome: A retrospective cohort study of 113 patients | 2021 | Cariti C.; Quaglino P.; Lupia T.; Novelli M.; Marra E.; Fava P.; Caliendo V.; Tonella L.; De Rosa F.G.; Fierro M.T.; Ribero S. |
10 | Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit | 2020 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T. |
11 | Nutritional interventions for patients with melanoma: From prevention to therapy—an update | 2021 | Pellegrini M.; D'eusebio C.; Ponzo V.; Tonella L.; Finocchiaro C.; Fierro M.T.; Quaglino P.; Bo S. |
12 | Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome | 2021 | Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S. |
13 | Predictive value of baseline [18f]fdg pet/ct for response to systemic therapy in patients with advanced melanoma | 2021 | Liberini V.; Rubatto M.; Mimmo R.; Passera R.; Ceci F.; Fava P.; Tonella L.; Polverari G.; Lesca A.; Bello M.; Arena V.; Ribero S.; Quaglino P.; Deandreis D. |
14 | Prognostic and predictive biomarkers in stage iii melanoma: Current insights and clinical implications | 2021 | Tonella L.; Pala V.; Ponti R.; Rubatto M.; Gallo G.; Mastorino L.; Avallone G.; Merli M.; Agostini A.; Fava P.; Bertero L.; Senetta R.; Osella-Abate S.; Ribero S.; Fierro M.T.; Quaglino P. |
15 | Treatment of Advanced Metastatic Melanoma | 2021 | Quaglino, Pietro; Fava, Paolo; Tonella, Luca; Rubatto, Marco; Ribero, Simone; Fierro, Maria Teresa |
16 | Treatment of early-phase mycosis fungoides: results from the Prospective Cutaneous Lymphoma International (PROCLIPI) study | 2019 | Quaglino, Pietro; Scarisbrick, Julia; Prince, Miles; Papadavid, Evangelina; Hodak, Emilia; Child, Fiona; Whittaker, Sean; Bagot, Martine; Querfeld, Christina; Akilov, Oleg; Servitje, Octavio; Berti, Emilio; Ortiz-Romero, Pablo; Stadler, Rudolf; Knobler, Robert; Mitteldorf, Christina; Estrach, Teresa; Marschalko, Marta; Guenova, Emmanuella; Pimpinelli, Nicola; Zocchi, Lamberto; Tonella, Luca; Beylot-Barry, Marie; Wobser, Marion; Wehkamp, Ulrike; Cowan, Richard; Vakeva, Liisa; Busschots, Annemie; Matin, Rubeta; Evison, Felicity; Hong, Eric; Vermeer, Maarten; Cerroni, Lorenzo; Kempf, Werner; Willemze, Rein; Kim, Youn |